Search
for
Sort by
Research 691–720 of 1000+
- Hormonal Therapy for Acne
- Ritlecitinib: First Approval
- Safety of testosterone treatment in postmenopausal women
- Management of acne
- Current evaluation of amenorrhea
- Management of Hair Loss
- Management of congenital ichthyoses: European guidelines of care, part two
- Mechanism of Sleep Disturbance in Children with Atopic Dermatitis and the Role of the Circadian Rhythm and Melatonin
- DRUG‐ASSOCIATED ALOPECIA
- A Scarless Healing Tale: Comparing Homeostasis and Wound Healing of Oral Mucosa With Skin and Oesophagus
- Systemic treatments for alopecia areata: A systematic review
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Hormonal Treatment of Transgender Women with Oral Estradiol
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- PCOS in Adolescence and Type 2 Diabetes
- Efficacy of Platelet-Rich Plasma Therapy in Oral Lichen Planus: A Systematic Review
- Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Cutaneous Lupus Erythematosus Presenting as Frontal Fibrosing Alopecia: Report of 2 Patients
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)
- Trichologist, Dermatotrichologist, or Trichiatrist? A Global Perspective on a Strictly Medical Discipline
- Associations among hair loss, oral sulfur-containing gases, and gastrointestinal and metabolic linked diseases in Japanese elderly men: pilot study
- Topical medication instillation techniques for glaucoma
- The Effectiveness of Oral Mini-Pulse Methylprednisolonein - the Treatment of Alopecia Areata in Vietnam
- Bullous Lichen Planus treated with Oral Minipulse Therapy: A Rare Case Report
- Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Contraindicated use of 5-alpha-reductase inhibitors in women
- CONTRACEPTION AND THE SKIN